social security cards

Additional Reports Show That The Future of Medicare and Social Security Looks Bleak as the risk of Insolvency advances without attention to deficit

We recently published a blog on the impending crisis concerning funding of Medicare and Social Security benefits. The numbers of inquiries on this were substantial so I am writing additional information on the problem. One issue is that Congress appears reluctant to address the issue especially given the coming...
Continue reading…
pink pill

Drug companies pay $122 million to settle case charging kickbacks including bribery to patients under the guise of charitable organizations on co-pays

Jazz Pharma, Alexion, and Lundbeck were the subject of SOJ lawsuits asserting kickbacks and committing general violations of Medicare laws. The United States Department of Justice has decided to agree to a settlement of $122.6 million in total from these three alleged Medicare violators. The drug companies were accused of...
Continue reading…

U.S. Government intervenes in case against Sutter Health for submission of false claims in Medicare Advantage plans

The United States has intervened in a complaint against Sutter Health LLC, a California-based healthcare services provider, and an affiliated entity, Palo Alto Medical Foundation, (collectively "Sutter") that alleges that Sutter violated the False Claims Act by submitting inaccurate information about the health status of beneficiaries enrolled in Medicare Advantage Plans, the Justice Department...
Continue reading…

Drug manufacturer Actelion pays $360 Million to end kickbacks case using foundation to pay Medicare copays for high blood pressure meds

Pharmaceutical manufacturer Actelion Pharmaceuticals US, Inc. (Actelion), will pay $360 million to settle claims that it illegally used a foundation as a conduit to pay the copays of thousands of Medicare patients taking Actelion's pulmonary arterial hypertension drugs, in violation of the False Claims Act. The government says that...
Continue reading…

Medical device maker to pay $17.9 million to end case for violation of FDA laws in whistleblower case

Medical device manufacturer ev3 Inc. has agreed to plead guilty to charges related to its neurovascular medical device, Onyx Liquid Embolic System, and pay $17.9 million, the Department of Justice announced today.ΠCovidien LP, whose parent acquired ev3, separately paid $13 million to resolve False Claims Act allegations resulting from its alleged payment of...
Continue reading…